Venous Thrombosis Management and Post-Thrombotic Outcomes

The management of venous thrombosis has evolved from standard anticoagulation towards an integrated approach that encompasses pharmacological prophylaxis, mechanical strategies and interventional techniques. Primary prevention of deep vein thrombosis centres on risk stratification and the judicious use of low-molecular-weight heparins, direct oral anticoagulants and, in selected high-risk surgical or immobile patients, mechanical prophylaxis. In acute deep vein thrombosis, prompt initiation of anticoagulation minimises thrombus propagation and reduces the incidence of post-thrombotic syndrome, a chronic complication characterised by pain, swelling and venous ulceration. Recent practice has seen a resurgence of catheter-directed thrombolysis and percutaneous mechanical thrombectomy for extensive iliofemoral thromboses in patients with low bleeding risk. Such interventions aim to restore venous patency, preserve valve function and improve long-term quality of life. Beyond acute care, long-term management focuses on compression therapy, tailored exercise regimes and surveillance for recurrent events. Despite these advances, up to half of treated individuals develop post-thrombotic sequelae, underscoring the need for robust predictors and personalised strategies to prevent chronic venous insufficiency and optimise functional outcomes worldwide.

Research from Nature Portfolio

Investigations have established a clinical scoring system to predict the likelihood of post-thrombotic syndrome after lower limb thrombosis. Four independent factors—residual femoropopliteal and iliac vein thrombus, insufficiency of anticoagulation and coexisting vein compression—were integrated into a composite index, which demonstrated over 80% accuracy in both development and validation cohorts. This tool enables early identification of high-risk patients, guiding intensity of follow-up, duration of anticoagulation and the consideration of adjunctive interventions to prevent long-term morbidity.

Venous Thrombosis Management and Post-Thrombotic Outcomes publication trend

The graph below shows the total number of articles in venous thrombosis management and post-thrombotic outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Deep vein thrombosis (DVT): Formation of a blood clot within a deep vein, most commonly in the lower limbs.

Post-thrombotic syndrome (PTS): A chronic condition following DVT, marked by pain, swelling, skin changes and ulceration due to venous hypertension.

Anticoagulation: Pharmacological inhibition of clotting pathways to prevent thrombus extension and recurrence.

Catheter-directed thrombolysis (CDT): Localised infusion of fibrinolytic agents via a venous catheter to dissolve thrombus.

Percutaneous mechanical thrombectomy (PMT): Device-assisted removal of venous thrombus through minimally invasive vascular access.

Stenting: Deployment of an intravascular scaffold to maintain venous lumen patency after thrombus removal.

Villalta score: A clinical scale combining symptoms and signs to quantify severity of post-thrombotic syndrome.

References

1. Single-Session Percutaneous Mechanical Thrombectomy Using the Aspirex®S Device Plus Stenting for Acute Iliofemoral Deep Vein Thrombosis: Safety, Efficacy, and Mid-Term Outcomes. Diagnostics (2020).
2. Risk factors and classification of reintervention following deep venous stenting for acute iliofemoral deep vein thrombosis. Journal of Vascular Surgery Venous and Lymphatic Disorders (2022).
3. Assessment of the Probability of Post-thrombotic Syndrome in Patients with Lower Extremity Deep Venous Thrombosis. Scientific Reports (2018).